Bristol-Myers Squibb Co (Bristol-Myers Squibb Co) ROE % Adjusted to Book Value : 0.00% (As of Mar. 2024)

View and export this data going back to 1990. Start your Free Trial

What is Bristol-Myers Squibb Co ROE % Adjusted to Book Value?

Bristol-Myers Squibb Co's ROE % for the quarter that ended in Mar. 2024 was -207.51%. Bristol-Myers Squibb Co's PB Ratio for the quarter that ended in Mar. 2024 was N/A. Bristol-Myers Squibb Co's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was N/A.

Bristol-Myers Squibb Co ROE % Adjusted to Book Value Historical Data

The historical data trend for Bristol-Myers Squibb Co's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bristol-Myers Squibb Co ROE % Adjusted to Book Value Chart

Bristol-Myers Squibb Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

Bristol-Myers Squibb Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Bristol-Myers Squibb Co's ROE % Adjusted to Book Value

For the Drug Manufacturers - General subindustry, Bristol-Myers Squibb Co's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bristol-Myers Squibb Co's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bristol-Myers Squibb Co's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Bristol-Myers Squibb Co's ROE % Adjusted to Book Value falls into.

Bristol-Myers Squibb Co ROE % Adjusted to Book Value Calculation

Bristol-Myers Squibb Co's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	26.53%	/	N/A
	=	N/A

Bristol-Myers Squibb Co's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-207.51%	/	N/A
	=	N/A

Bristol-Myers Squibb Co ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Bristol-Myers Squibb Co (Bristol-Myers Squibb Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (NYSE:BMY.R) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

BMYMP.PFD:USA BMY:USA BMY:Peru BMY:Mexico 1BMY:Italy BRMd:UK 0R1F:UK BRM:Germany BRM:Germany BRM:Germany BRM:Germany BMYB34:Brazil BMYS:Austria BMY:Argentina

Address

430 East 29th Street, 14th Floor, New York, NY, USA, 10016

Website

https://www.bms.com

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.